These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25531166)

  • 1. Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia.
    Chea S; Cheng YB; Chokephaibulkit K; Chotpitayasunondh T; Rogier van Doorn H; Hafy Z; Kawichai S; Liu CC; Nam NT; Ooi MH; Wolbers M; Zeng M
    Emerg Infect Dis; 2015 Jan; 21(1):. PubMed ID: 25531166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hand-foot-mouth disease and use of steroids, intravenous immunoglobulin, and traditional Chinese herbs in a tertiary hospital in Shantou, China.
    Zhang D; Chen J; Ba-Thein W
    BMC Complement Altern Med; 2018 Jun; 18(1):190. PubMed ID: 29925360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial.
    Qui PT; Khanh TH; Trieu HT; Giang PT; Bich NN; Thoa le PK; Nhan le NT; Sabanathan S; Van Doorn R; Toan ND; Merson L; Dung NT; Khanh LP; Wolbers M; Hung NT; Chau NV; Wills B
    Trials; 2016 Feb; 17():98. PubMed ID: 26896318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Different Doses of Intravenous Immunoglobulin on Severe Hand, Foot and Mouth Disease: A Meta-Analysis.
    Jiao W; Tan SR; Huang YF; Mu LH; Yang Y; Wang Y; Wu XE
    Med Princ Pract; 2019; 28(3):256-263. PubMed ID: 30646003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the efficacy and safety of magnesium sulfate for management of autonomic nervous system dysregulation in Vietnamese children with severe hand foot and mouth disease.
    Phan QT; Phung LK; Truong KH; Huynh TT; Phạm GT; Nguyen BN; Tran QT; Huynh VNT; Nguyen TTM; Le TPK; Le NNT; Sabanathan S; van Doorn HR; Van Le T; Nguyen TD; Merson L; Nguyen DTP; Geskus R; Nguyen HT; Nguyen CVV; Wills B
    BMC Infect Dis; 2019 Aug; 19(1):737. PubMed ID: 31438878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of intravenous immunoglobulin therapy for severe hand-foot-mouth disease: a review].
    Cao R; Han J; Qin E; Qin C
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):712-6. PubMed ID: 21845837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trend of epidemics and variation of pathogens of hand, foot and mouth disease in China: a dynamic series analysis, 2008-2017].
    Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):147-154. PubMed ID: 30744263
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Efficacy of Early Administration of Human Immunoglobulin on Children with Severe Hand-foot-mouth Disease.
    Wu H; Li L
    J Coll Physicians Surg Pak; 2023 Feb; 33(2):234-236. PubMed ID: 36797638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.
    Soares MO; Welton NJ; Harrison DA; Peura P; Shankar- Hari M; Harvey SE; Madan JJ; Ades AE; Palmer SJ; Rowan KM
    Health Technol Assess; 2012; 16(7):1-186. PubMed ID: 22361003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.
    Aswathyraj S; Arunkumar G; Alidjinou EK; Hober D
    Med Microbiol Immunol; 2016 Oct; 205(5):397-407. PubMed ID: 27406374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of Jinzhen oral liquid for hand foot and mouth disease: a randomized, multi-center, double-blind, placebo-controlled trial.
    Liu J; Zhang GL; Huang GQ; Li L; Li CP; Wang M; Liang XY; Xie D; Yang CM; Li Y; Sun XR; Zhang HS; Wan BS; Zhang WH; Yu H; Zhang RY; Yu YN; Wang Z; Wang YY
    PLoS One; 2014; 9(4):e94466. PubMed ID: 24722423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for necrotizing soft tissue infections in adults.
    Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for death in children with severe hand, foot, and mouth disease in Hunan, China.
    Long L; Gao LD; Hu SX; Luo KW; Chen ZH; Ronsmans C; Zhou DL; Lan YJ
    Infect Dis (Lond); 2016 Oct; 48(10):744-8. PubMed ID: 27195893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct medical costs and influencing factors in severe hand, foot and mouth disease in children aged between six months and five years old].
    Zheng YM; Yang J; Liao QH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jan; 51(1):87-92. PubMed ID: 28056277
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent progress and challenges in drug development to fight hand, foot and mouth disease.
    Lim ZQ; Ng QY; Ng JWQ; Mahendran V; Alonso S
    Expert Opin Drug Discov; 2020 Mar; 15(3):359-371. PubMed ID: 31470744
    [No Abstract]   [Full Text] [Related]  

  • 17. Spatial Clustering of Severe Hand-Foot-Mouth Disease Cases on Hainan Island, China.
    Chen SM; Qiu L; Du ZH; Jin YM; Du JW; Chen Y; Watanabe C; Umezaki M
    Jpn J Infect Dis; 2017 Nov; 70(6):604-608. PubMed ID: 28890503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Temporal and spatial clustering characteristics and changes of severe hand, foot, and mouth disease in mainland of China, from 2008 to 2013].
    Yu S; Zhou Z; Yang F; Xiao G; Ma J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):271-5. PubMed ID: 24831625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.
    Ng Q; He F; Kwang J
    Viruses; 2015 Dec; 7(12):6441-57. PubMed ID: 26670245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
    Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
    BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.